Treatment Patterns and Outcomes in Patients With Lower-risk Myelodysplastic Syndromes Treated With Luspatercept in China
NCT07073690
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
80
Enrollment
INDUSTRY
Sponsor class
Conditions
Myelodysplastic Syndromes
Interventions
DRUG:
Luspatercept
Sponsor
Bristol-Myers Squibb